
About
the LIMSource
This site provides detailed information about Laboratory Information Management
Systems (LIMS)
Applications
Links to various application-specific LIMSource pages, such
as pharmaceutical, environmental, biotech, etc.
Calendar
Conferences, trade shows, seminars, etc. that highlight LIMS, informatics,
and lab data management issues
Classified Ads
A careers section of classified ads from organizations seeking LIMS professionals
Guest Book
If you are new to this site, please register with the Guest Book. Registrants
receive free LIMSource online newsletter
Library
Books, newsletters, and magazines as well as the LIMSzine and a list of "Interesting
Places to Visit"
LIMS/Letter
Details about the LIMS/Letter, including an archive of all past issues
and an online ordering form
LIMS
Primer CD
Unique CD-ROM delivers a capsule look at LIMS, from tutorials and advice,
to selected LIMS/Letter articles, to a short list of top LIMS vendors
LIMS
Products & Services
Comprehensive list of LIMS, and lab data automation products and services
available from vendors, consultants, and service/support providers
User Community
Lists of relevant associations as well as details about the LIMS Institute
and LIMS Mailing List User Group
What's New
About What's News
What's New in the Industry
What's New in this Web Site
Copyright
© LIMSource.
All Rights Reserved
Legal Notice.
•
Chenomx Releases Major Upgrade to Metabolomics Software
Suite
• New NI Smart Cameras Powered by
LabVIEW
• New NanoMarkets Report Predicts $15.8 Billion
Organic Electronics Materials Market in 2015
• WinLIMS Rental Solution Improves Efficiency at
Contract Lab
• Labtronics Announces Collect 6.1
• Waters Announces SystemsQT Qualification Tool
and New MassPREP OST Standard
• Cambridge Biotech Software, Inc. Announces
POLARIS
• Thermo Fisher Scientific To Implement Darwin
LIMS at APP Pharmaceuticals Inc.
• Northwest Analytical Announces New White Paper
Detailing 21st Century Process Management Using SPC Based Manufacturing Analytics
• University of Alberta Transplant Applied Genomics
Centre Chooses Scientific Data Management Solution from GenoLogics
• Labtronics Upgrades Empower to LIMS Interface
• Thermo Fisher Scientific Appoints Puerto Rico
Partner Quality Instruments Solutions (QIS) to Support Informatics Sales
• Thermo Fisher Scientific Extends Informatics
Offering into Venezuela and the Caribbean
Signs Agreement with Controval
• Ethosoft Provides More Web-Browser Based Features
with the Release of X-LIMS Version 2.2
• SAWLA Implements Bika Interlab 1.2 Proficiency
Testing Software
• VelQuest Partners with Autoscribe
Ltd and Zumatrix, Inc. to Provide a LIMS Stability Study Module for Pharmaceutical
Quality Operations
• Compendia Bioscience Signs Oncomine
Licensing Agreement with AstraZeneca
• D-Tools System Integrator Named as Gold Winner
in 2007 CE Pro High Impact Products Awards
• ACD/Labs Releases PhysChem Version 11.0
• Thermo Fisher Scientific Launches MetWorks
1.1.0 Metabolite Identification Software
• Xendo Drug Development Licenses LabVantage's
Sapphire to Improve Laboratory Data Flow In Its Bioanalysis and Drug Metabolism
Unit
• PerkinElmer Announces Localized Language ICP WinLab32
Software
• GenoLogics Announces Partnership with London Genetics
• Thermo Fisher Scientific Launches New Informatics
Customer Initiative
• Labtronics' Nexxis 4.0 Validation Toolkit
Speeds Up the Validation Process
• Matrix Software Chosen by Leading Pharmaceutical
Company
• Bruker BioSciences Reports Financial Results
for the Third Quarter of 2007
• RTS Life Science Extends its Bench Top Instrument
Range
• Labtronics Announces Fully Integrated LIMS
Interfacing for Chromeleon CDS
• Sapio Sciences Releases Copy Number Variation
(CNV) Analysis Tool For Illumina Infinium Arrays
• Bruker Companies Announce the Opening of a Modern
Chinese Applications,
Demonstration and Customer Training Center in Beijing
• QATrax Releases Management Reports Solution
for Test Labs
• PerkinElmer Introduces Series 200EP Photo Diode
Array Detector
• Thermo Fisher Scientific
Selected by China Doping Control Center to Supply Sports Doping Testing Instrumentation
at the 2008 Beijing Olympics
• GenoLogics
Welcomes New VP Finance and VP Products to Senior Management Team and Appoints
New Chair of the Board
• Savi Technology Taps Solar
Energy to Power RFID-Based Asset Tracking Systems
• Labtronics
Reintroduces Collect Licensing Plan
Cambridge
Biotech Software, Inc. Announces POLARIS
Cambridge Biotech Software, Inc. has announced their new lab product POLARIS,
a global Patient Lab Results Reporting System that supports the receipt of
patient lab data from both Laboratory Information Management Systems (LIMS)
and non-LIMS systems and provides the ability to generate letters to report
those results to Health Care Professionals (HCP) worldwide. POLARIS is a client
server distributed database solution that’s designed with customizable
data import modules which allow data sets to be accepted from multiple sources.
Features include: Contact Management; Letter Generation; Automated Data Feeds;
Custom Reports; and Bult-in Compliance. Cambridge Biotech Software provides
software, consulting, and custom software services to Biotech, Pharma, and
Life Science companies. They provide software services that include Project
Management; Business Analysis; Software Development; Testing; and, Validation.
For details, visit http://www.cambiosoft.com/POLARIS_by_Cambiosoft.pdf.
Thermo Fisher Scientific To Implement Darwin
LIMS at APP Pharmaceuticals Inc.
Thermo Fisher Scientific Inc., the world leader in serving science, has been
selected by APP Pharmaceuticals Inc. (formerly known as Abraxis Pharmaceutical
Products) for a three site multi-phase rollout of Thermo Scientific Darwin
LIMS. Darwin, a purpose-built LIMS for pharmaceutical manufacturing R&D
and QA/QC, will be deployed in all three of APP’s manufacturing facilities
located in New York, Illinois and Puerto Rico. APP Pharmaceuticals’
products have helped millions of people in the United States and Canada fight
critical illnesses by providing a broad portfolio of multi-source and branded
injectable pharmaceutical products, including difficult to manufacture and
urgently needed medical products. The project is intended to harmonize processes,
automate operations and consolidate data management in a single LIMS across
all three sites. The multi-phase project will initially involve the deployment
of Darwin’s inherent Environmental Monitoring functionality enabling
facilities to move from manual systems onto an automated system for microbiological
samples from the sterile manufacturing environment. The second phase of the
project will feature an integrated LIMS and Chromatography Data System (CDS)
implementation followed by the third phase of the LIMS rollout including SAP
interfaces across all sites. Hector Jimenez, Senior Director of Quality Operations
at APP, commented: “We selected Darwin LIMS because it offers purpose-built
functionality for pharmaceutical manufacturing - the solution is extremely
easy to configure and use for our environmental and our chemistry laboratories.
In addition, we are confident that Darwin LIMS will provide efficiency improvements
in the tracking of samples and in capabilities of trending data as well as
compliance.” For details, visit http://www.thermo.com/informatics.
Northwest Analytical Announces New White Paper
Detailing 21st Century Process Management Using SPC Based Manufacturing Analytics
Northwest Analytical, Inc. (NWA) has announced a new white paper, “21st
Century Process Management Using SPC Based Manufacturing Analytics”.
The paper details how process based manufacturing and business analytics enable
enterprise decision making. SPC based Manufacturing Analytics is statistical
and rule based, provides the aggregation, analysis and role-based visualization
and reporting of manufacturing data that enables users to better understand
and improve their processes, identify and reinforce best practices, react
quickly to process events, and anticipate potential problems before they affect
product quality, yield, or cost. SPC is fundamental to the corporate
need of better data analysis. It is how to make more effective use of all
the data in historians, MES, LIMS and ERP systems. It also allows for the
reduction of complex, specialized process data into graphic visualizations
which operations and management can quickly understand and from which informed
action can be taken. The white paper, “21st Century Process Management
Using SPC Based Manufacturing Analytics”, is available at http://www.nwasoft.com/appnotes/spc-based-ma.htm.
University of Alberta Transplant Applied Genomics
Centre Chooses Scientific Data Management Solution from GenoLogics
GenoLogics, a leading developer of lab and data management software solutions
for life sciences research, has announced that the University of Alberta has
selected Geneus for their informatics infrastructure and scientific data management
system. GenoLogics installed Geneus at the Alberta Transplant Applied Genomics
Centre (ATAGC) at the University of Alberta in September of this year. Today,
ATAGC is conducting diagnostic gene expression and transcriptomics research
with the aim to develop new molecular diagnostics for organ transplant recipients.
The research involves using gene expression microarrays to understand transplant
rejection events, and has led to the identification of a series of gene expression
(transcript) sets that provide new robust quantitative measurements for assessing
rejection. These sets form the basis of a potentially new diagnostic
system to use in conjunction with the current pathology system. In the
future, they expect to use proteomics and metabolomics research to augment
the research they are conducting, and they also plan to partner with pharmaceutical
organizations to develop commercial therapeutic drugs to counter organ rejection.
Dr. Philip Halloran, Director of the Alberta Transplant Applied Genomics Centre,
stated, “The challenge of applying the new sciences is that they are
so rich in data – in information. To be successful in bringing
the new genetic sciences to the bedside requires new approaches to managing
information. We are doing this in organ transplants now, but every area
of medicine will eventually be changed by these new technologies.” The
Geneus solution will be used primarily as a scientific data management system
(SDMS) to handle the data management component of the Centre’s gene
expression and transcriptomics research. Geneus will provide the research
informatics infrastructure to handle the Centre’s massive amount of
scientific data, for example, an Affymetrix GeneChip microarray with over
50,000 genes in a single experiment. Geneus also provides a powerful LIMS
which the Centre will use to handle lab operations and sample tracking and
management. The ATAGC is devoted to using microarrays and other methods
for gene expression both for new diagnostic insights and for exploring disease
mechanisms. The Centre is in the process of establishing a service where research
conducted on understanding the mechanisms and biological events associated
with rejection of transplanted organs may be made available to other labs,
institutions and clinicians. ATAGC has a unique database that houses gene
expression data that comes from patient biopsies along with the related patient
information, in which confidentiality and privacy are completely protected.
This comprehensive database provides a view of molecular events and how the
relate to clinical events, which can be used by researchers across multiple
sciences within the University of Alberta and elsewhere. Initially,
over 50 people consisting of lab technicians, researchers, bioinformaticians,
and physicians will access and use this system. The Geneus solution will scale
as the Centre expands and to enable collaboration between many remote users
(through GenoLogics’ LabLink web collaboration system) and access to
data across multiple labs. As the Genomics Centre grows, this configurable
informatics platform can be adapted on the fly to include processes and workflows
for other sciences. For details, visit http://www.genologics.com
or http://www.atagc.med.ualberta.ca.
Labtronics Upgrades Empower to LIMS Interface
Labtronics Inc. has announced that the upcoming new release of LimsLink CDS
will include an update to their seamless, embedded LIMS interface that allows
analysts to interact directly with their LIMS, from inside their Empower client.
The new release extends the functionality of the Empower interface to further
reduce the amount of time and resources that laboratories spend on setting
up Sample Set Methods. Enhancements have also been introduced to simplify
sharing of LimsLink CDS interfacing methods across multiple Empower Projects.
As a result, laboratories will be able to minimize the number of LimsLink
CDS interfacing methods they use and therefore reduce validation and support
requirements. The upgraded LimsLinkCDS embedded interface for Empower is part
of the upcoming LimsLink CDS release that also includes a new embedded interface
for Chromeleon and Labtronics' embedded interfaces for ChemStation and TotalChrom.
For details, visit http://www.labtronics.com/llcds.htm.
Thermo Fisher Scientific Appoints Puerto
Rico Partner Quality Instruments Solutions (QIS) to Support Informatics Sales
Thermo Fisher Scientific Inc. has established a new partnership with Puerto
Rico-based distributor QIS to extend its informatics offerings in the Caribbean.
The new distribution agreement allows QIS to support sales
activities in Puerto Rico and the wider Caribbean for the complete Thermo
Scientific informatics product range, focusing on LIMS and Chromatography
Data Systems (CDS). Dedicated sales experts will target a number of industries
which are strong in Puerto Rico, and which Thermo Fisher has long served,
including the pharmaceutical, petrochemical and chemical markets. Puerto Rico
is host of one of the largest concentration of pharmaceutical manufacturers
in the world, and QIS is strategically placed to provide locally-based companies
with the full range of Thermo Scientific informatics solutions. QIS already
successfully supplies and supports Thermo Scientific instruments in Puerto
Rico, and aims to strengthen the company's informatics offering in Puerto
Rico through this new partnership. Customers will now have access to Thermo
Fisher's full informatics portfolio including Darwin LIMS, Atlas CDS, SampleManager
and GRAMS. For details, visit http://www.thermo.com/informatics.
Thermo Fisher Scientific Extends Informatics
Offering into Venezuela and the Caribbean
Signs Agreement with Controval
Thermo Fisher Scientific Inc. has signed an agreement with Caracas-based Controval,
C.A. to operate an authorized sales center for Thermo Scientific informatics
solutions in Venezuela and the Caribbean. Under the terms of the partnership,
Controval will be providing professional sales services to local customers
in a number of industries, which Thermo Fisher has long served, including
Pdvsa Oil and Gas and Pdvsa Refinery, Intevep Pdvsa, Pequiven, Cvg Fmo; Sidor;
Venalum and Biotech. Controval will be promoting the complete range of Thermo
Scientific informatics solutions including LIMS, Chromatography Data Systems
(CDS), pharmacokinetic-pharmacodynamic and spectroscopy software and spectral
libraries. The collaboration will be extended at a later date to supplement
the sales activities by offering after-sales support and technical consultation
services. Oliver Faidi Cortés, director of Latin America and Caribbean
sales for informatics at Thermo Fisher Scientific, explains: “This new
partnership underscores our commitment to our customers based in Latin America
and the Caribbean. Controval serves the Venezuelan market providing them with
integral solutions in instrumentation and industrial automation. The company
holds a deep knowledge of the requirements of the industry with regards to
new technology. Furthermore, Controval has an established sales organization
consisting of seven sites spread throughout Venezuela and has been a long-term
distributor of Thermo Scientific process instruments. This pedigree makes
Controval an ideal partner capable of extending our presence to this vital
region.” Miguel Ángel Benítez, general manager at Controval,
adds: “Our business philosophy is to offer the best technological products
and the most sophisticated services in order to help our customers achieve
the highest levels of excellence in their industrial processes. Thermo Fisher
Scientific shares the same vision, thus we are confident that this collaboration
will be utterly successful.” For details, visit http://www.thermo.com/informatics.
Ethosoft
Provides More Web-Browser Based Features with the Release of X-LIMS Version
2.2
In keeping with its goal of providing class leading features using current
web-browser and XML technologies, Ethosoft has released the Xchange Suite
in version 2.2 of their X-LIMS. Xchange contains the instrumentXchange and
documentXchange utilities. Within
instrumentXchange, laboratories may integrate their own instrumentation routines
without custom development right through the browser. The documentXchange
component has also been included with this release. It provides a browser
based control panel which provides an easy to use and flexible interface allowing
laboratories to manage their reference/controlled documents within the LIMS
and the users the ability to access these centrally stored reference documents
right from their web-browser. For details, visit http://www.ethosoft.com.
SAWLA Implements Bika Interlab 1.2 Proficiency
Testing Software
The web based inter-laboratory proficiency testing system designed and sponsored
by the South African Wine Laboratory Association (SAWLA) and developed locally
in open source technologies by Bika Lab Systems, went into production February
2007 and proved very successful, eliminating the three week turn around experienced
with the spread sheet based system it replaced Effective proficiency testing
is one of the tools employed by SAWLA towards its goal to improve the quality
of wine laboratories in SA, standardise methodology and provide a forum for
communication and access to information. The proficiency testing scheme (PTS)
runs on a monthly basis, two different wine samples per month. The scheme
co-ordinator validates bulk samples as homogeneous in an ISO 17025 accredited
laboratory, bottles and distributes the samples. Member labs then have a week
to analyse the samples, on 15 different parameters, and submit their results
on-line. In the on-line system it works like this: The PTS co-ordinator prepares
the samples and creates a testing round on-line at the SAWLA web portal. The
system automatically informs members per e-mail and provides relevant information
about the sample type, distribution and closing date. Member labs fetch their
samples, analyse them and enter their results on-line. A senior analyst or
manager verifies the data. After their results were verified, and enough verified
results are available to make statistical sense, members may immediately see
their comparative stats and performance indicators. They are warned though
that these remain dynamic as more labs submit their data. When the testing
round closes, members receive their final performances per e-mail. Analysis
results are archived and presented to members graphically via distribution
curves, method comparisons and chronological Z-value plots. The system delivers
immediate turnaround. Since the SAWLA system is built on a Content Management
System (CMS) platform, it offers benefits in a dynamic interactive web portal
at www.sawla.org. The SAWLA portal currently offers a Help centre with training
videos, member list and statistics explanations . The system's CMS capabilities
will now be exploited to the fullest in SAWLA's drive to have the system certified
ISO compliant. It will serve as document repository for SAWLA's quality control
manual, year plan, complaints register, corrective and preventative action
forms and register, internal audits, management reviews and skills development
packages. For details, visit http://www.bikalabs.com.
VelQuest Partners with Autoscribe Ltd and Zumatrix to Provide a LIMS
Stability Study Module for Pharmaceutical Quality Operations
VelQuest Corporation, the developer of the SmartLab GMP Electronic Notebook
System, and Autoscribe Ltd., a LIMS provider, have announced an integration
partnership to support a major multi-site pharmaceutical company. The company
is implementing the VelQuest SmartLab GMP Electronic Notebook System for QC/QA
cGMP laboratory execution, instrument integration and data capture with integration
directly to SAP. To comprehensively design protocols and manage stability
data, VelQuest and the client’s choice is the Matrix Stability System,
developed by Autoscribe, Ltd. and supplied in the USA by Zumatrix, Inc. This
close partnership provides a seamless protocol driven integration with the
following key capabilities: Protocol Management; Study Maintenance Management;
Batch Maintenance Management; Location Management; Inventory Management; Reports;
Statistical Analysis; and, Lab Procedure Execution. "The Matrix Stability
System was designed in cooperation with several pharmaceutical companies and
our US Distributor, Zumatrix, Inc.”, says John Boother, Managing Director
of Autoscribe. “At our joint client’s multi-site quality organization,
VelQuest’s SmartLab platform and the Matrix Stability System combine
“best-of-breed” method execution, data capture and stability protocol
design and data management for cGMP operations”. "A major goal
in many companies is to eliminate the routine, non-value added and error-prone
tasks through automation”, said Ken Rapp, President and CEO of VelQuest.
“A key issue in the pharmaceutical industry is that a significant amount
of people are dedicated to regulatory compliance functions that use costly
paper-based processes. The SmartLab software has been deployed in cGMP facilities
worldwide. Users have reported their ability to eliminate the paper-based
data capture and documentation processes creating annual operational benefits
yielding millions of dollars in efficiency gains. The integration of the Matrix
Stability Study System with SmartLab provides a comprehensive protocol design,
method execution, automated data capture and compliant documentation management
capability for this critical process in cGMP quality operations”. For
details, visit http://www.autoscribe.co.uk.
Compendia Bioscience Signs Oncomine Licensing
Agreement with AstraZeneca
Compendia Bioscience,
Inc. has announced that it has licensed Oncomine - the company’s compendium
of oncology gene expression profiles and analysis tools - to AstraZeneca,
which will conduct a yearlong pilot to evaluate the long-term role of this
product in its cancer research programs. This licensing agreement gives AstraZeneca
access to Oncomine Concepts Edition (OCM), a value-added product extension
of Oncomine that combines nearly 7,000 proprietary cancer gene signatures
with 11,000 gene, protein, drug, and pathway signatures collected from the
literature and other public sources. The Concepts Map application uses gene
sets as a common language to compare and link disparate biological concepts,
allowing researchers to discover and explore new biology based on signatures
related to drugs and/or disease pathways. A recent study published in Nature
Genetics (2007 Jan; 39(1): 41-51) used Oncomine Concepts Map to analyze prostate
cancer gene expression in the context of the other gene signatures available
in OCM. The result was an important new model describing the progression of
prostate cancer. Oncomine Concepts Map is licensed to commercial users as
part of the Oncomine Concepts Edition and the Oncomine Enterprise Edition.
For details, visit http://www.compendiabio.com.
D-Tools System Integrator Named as Gold Winner
in 2007 CE Pro High Impact Products Awards
D-Tools, Inc., a leader in system integration software, has announced that
D-Tools System Integrator 5 software has been named a 2007 CE Pro Impact Products
Awards Gold Winner. The annual “Best of” contest rates home-technology
products based on feedback from the professionals who sell, specify and install
the goods. CE Pro, a publication for the custom electronics industry, invited
its 35,000 readers to suggest products that helped them win more customers,
save time on the jobsite or otherwise make more money in 2007. The editors
of CE Pro magazine polled thousands of its readers who indicated their favorite
time-saving, money-making, customer-pleasing, high-impact products of the
year. D-Tools’ SI5 was selected among dealers/installers as a Gold Level
High Impact Product of 2007. D-Tools’ System Integrator (SI) is a total
design solution that utilizes Autodesk AutoCAD and Microsoft Visio for comprehensive
system design, documentation and project management. D-Tools SI allows commercial
integrators to streamline their business processes to increase overall revenues
while reducing the time and costs associated with the installation and integration
of low-voltage systems. For details, visit http://www.d-tools.com.
ACD/Labs Releases PhysChem Version 11.0
Advanced Chemistry Development, Inc. (ACD/Labs) has released the latest version
of ACD/Labs PhysChem software. Version 11 provides updated molecular property
predictions for a broader variety of chemical classes through enhanced models;
and offers a new customizable interface for instant interactive review of
results. Version 11 includes a new logP prediction model based on experimental
data from more than 25,000 compounds. Substantial increase of the internal
database (the training set) from version 10, with experimental data, has expanded
and diversified chemical space coverage, particularly for compounds of pharmaceutical
interest. Enhancements to ACD/pKa DB come from the addition of over 2,500
new compounds and experimental data into the training database, resulting
in increased chemical space coverage and greater prediction accuracy. Since
the PhysChem product line is heavily integrated, improvements to the logP
and pKa models augment the prediction quality of ACD/Labs entire range of
predictive software products. For details, visit http://www.acdlabs.com/physchemlab.
Thermo Fisher Scientific Launches MetWorks
1.1.0 Metabolite Identification Software
Thermo Fisher Scientific Inc. has launched MetWorks 1.1.0, an updated version
of its proven metabolite identification software. Thermo Scientific Metworks
1.1.0 software facilitates automated acquisition, processing and reporting
of LC/MS data in support of biotransformation studies. MetWorks software is
compatible with all Thermo Scientific mass spectrometers capable of performing
MS/MS and MSn fragmentation. In addition, MetWorks allows high resolution
accurate mass data from the Thermo Scientific LTQ Orbitrap and LTQ FT instruments
to be fully leveraged. MetWorks 1.1.0 software features enhanced tools that
facilitate distinguishing xenobiotic components from endogenous biological
matrix interferences in LC/MSn chromatograms and spectra. Key improvements
to the software include: Automatic generation of a Data-Dependent Parent Mass
Table (DDPT); Component filtering to exclude duplicates originating from adducts
and isotopic contributions; and, Flexibility to apply up to six multiple mass
defect filters (MMDF’s). Integration of Mass Frontier predictive fragmentation
software within the MetWorks 1.1.0 workflow process has greatly improved the
assessment for automated metabolite identification studies. Mass Frontier
predictive fragmentation tools significantly decrease the time researchers
require to confidently identify and generate lists of drug metabolites. MetWorks
1.1.0 collates and converts this information, including calculated elemental
formulae, chemical structures and chromatograms into easy-to-read reports.
In addition, the software supports storage of user-generated mass spectral
libraries. For details, visit http://www.thermo.com/metabolism.
Xendo Drug Development Licenses LabVantage's
Sapphire to Improve Laboratory Data Flow In Its Bioanalysis and Drug Metabolism
Unit
LabVantage has announced that its Sapphire LIMS has been licensed by Xendo,
a leading, independent consultancy, contract research and project management
organization in the life sciences, pharmaceutical and
healthcare fields. Based in the Netherlands and providing services in Holland,
Sweden and Denmark, Xendo's goal is to enhance the quality and safety of medicine
and help shorten the time to market for drugs and medical devices that improve
quality of life. The Bioanalysis and Drug Metabolism (BDM) business unit's
primary responsibility is the analysis of preclinical and clinical samples.
The unit's existing processes rely heavily on manual interaction throughout
the sample lifecycle. In order to increase speed and enhance quality, Xendo
required a solution to minimize the number of manual data processing steps.
They also needed to increase the speed and reliability of reporting data as
well as the traceability of the process parameters. "The Sapphire solution
met all of our needs and more. In addition to automating and expediting the
analysis process, we needed a solution that also delivered functionality to
integrate our laboratory instrumentation into our testing regime," explained
Jaap Wieling, Managing Director of Xendo. "The Sapphire next generation
technology platform with its thin client accessibility, built-in workflow
configurability and ease of interoperability with third party instruments
were the deciding factors in our selection of Sapphire." For details,
visit http://www.xendo.com or http://www.labvantage.com.
PerkinElmer Announces Localized Language ICP
WinLab32 Software
PerkinElmer has announced the availability of its WinLab32 software with a
complete Japanese and Simplified Chinese user interface to offer convenience
and support for PerkinElmer’s user base in China and Japan. The
software is compatible with the Optima line of Inductively Coupled Plasma-Optical
Emission Spectroscopy (ICP-OES) systems. WinLab32 requires the Windows XP
Service Pack 2 to give customers all the tools needed to analyze samples,
report and archive data, and ensure regulatory compliance. The new releases
of WinLab32 provide support for: Ethernet connectivity on the Optima 5x00
series ICP; Integration of the new PerkinElmer S10 Autosampler; The
latest generation of computer hardware; and, Improved software usability.
For details, visit
http://las.perkinelmer.com/Catalog/default.htm?CategoryID=ICP+Optical+Emission+%5bICP-OES%5d.
GenoLogics Announces Partnership with London
Genetics
GenoLogics, a leading developer of lab and data management software solutions
for life sciences research, has announced it will work closely with London
Genetics Ltd., a commercial company whose purpose is to facilitate and manage
partnerships between the health care industry and centers of biomedical excellence
in London, to identify opportunities for collaboration. GenoLogics will help
promote London Genetics’ efforts in building an extensive research network
of scientists and clinicians through joint workshops and scientific forums.
As London Genetics builds different combinations of discrete biological, experimental
and bioinformatics expertise and resources across London, GenoLogics will,
where appropriate, provide advice and expertise to ensure that a suitable
lab informatics infrastructure is in place to manage these complex networks.
GenoLogics and London Genetics will also work together to identify collaborative
projects and grant funding opportunities. Through its partners, London Genetics
can provide access to a wide range of offerings including, well-defined clinical
and population cohorts, tissue banks, ‘omics’ software and technologies
as well as access to key opinion leaders from multiple disciplines and therapeutic
areas. Through this partnership, GenoLogics will provide complementary expertise
to potential London Genetics consortia in the area of informatics infrastructure.
Projects will be able to take advantage of their OMIX lab informatics platform
coupled with purposed proteomics (Proteus) and genomics (Geneus) modules to
help provide a multi-lab and multi-science platform with a common database
for all consortia partners, independent of role. This will in turn help allow
each partner to rapidly interchange and share their leading edge research
data reducing to a minimum data redundancy and time consuming manual transcriptions
of data, while increasing the opportunities to automatically capture instrument
based experimental data and perform downstream data analysis options. So that
all partners are provided with data with a high level of provenance and security,
which in turn will help support and secure novel discoveries. Imperial College
London and St George’s, University of London, both existing GenoLogics
customers, are two of the seven leading research institutions supporting London
Genetics. London Genetics’ additional Partners are The Institute of
Cancer Research, King’s College London, The London School of Hygiene
and Tropical Medicine, Queen Mary, University of London and University College
London. For details, visit http://www.genologics.com.
Thermo Fisher Scientific Launches New Informatics
Customer Initiative
Thermo Fisher Scientific Inc. has announced an internal process improvement
initiative within its global laboratory informatics (LIMS) line of business.
The CARES Initiative (Customer Allegiance through Responsive, Excellent Service)
encompasses all phases of product development, sales and service, and demonstrates
the division's commitment to exceeding customer expectations across all operational
levels. This new initiative will be launched at Thermo Informatics World (TIW)
North American and European user meetings that take place in Miami, Florida
from October 15 through 19, 2007 and in Lisbon, Portugal from November 12
through 16, 2007. The CARES Initiative is built upon a platform of seven core
principles, which demonstrate the division's commitment to customer allegiance
and customer satisfaction in areas such as product performance, order fulfillment,
technical support, and sales and account management. A documented Quality
Management System is built into every aspect of the business and supported
by all levels of the organization. Reliable and rigorous external product
testing is also in place, including simulated multi-user environments and
benchmarking to measure quality, performance and usability. A new eServices
portal will offer LIMS and CDS customers a wide range of support, including
on-line incident logging, monitoring and resolution of support enquiries,
as well as access to the business Knowledge Base. Thermo Scientific LIMS and
CDS customers will also benefit from a sophisticated issue resolution system,
which uses patented technology to capture a log of user actions and system
events to quickly determine the cause of unexpected application behavior.
Around-the-clock support is offered, ensuring that customers have access to
assistance wherever the business is located. As part of the CARES Initiative,
the LIMS and CDS line of business is promoting continuous communication and
customer feedback in order to constantly improve products and processes. The
CARES Initiative also ensures commitment from the highest levels of senior
management. For details, visit http://www.thermo.com/informatics.
Labtronics' Nexxis 4.0 Validation Toolkit
Speeds Up the Validation Process
Labtronics Inc. has announced the release of the Nexxis Validation Toolkit
to assist with the validation of Nexxis 4.0, a powerful web-based development
tool and deployment platform that is at the core of all of Labtronics’
Nexxis applications (Nexxis ELN, Nexxis CAL, Nexxis CIM, Nexxis ST, Nexxis
BDS). This latest release of the Nexxis Validation Toolkit speeds up the validation
process for Nexxis v4.0 by providing validation groups with detailed IQ and
OQ documents that significantly reduce the amount of time they spend compiling
the information that they require to initiate and execute a thorough IQ/OQ
validation of Nexxis 4.0. IQ documents provide a detailed listing of hardware
requirements, step-by-step descriptions of software installation procedures
and a listing of all required files showing the expected filename, size, and
version number. OQ documents include detailed testing procedures that guide
the user through verification of User Identification, Application Security,
Method Execution, etc. All Nexxis 4.0 applications share a common zero-footprint
web client, common security and audit trail, an instrument library and additional
laboratory specific capabilities and routines that facilitate a high level
of integration between all of these applications and other laboratory informatics
systems. For details, visit http://www.labtronics.com/nexxis.htm.
Matrix Software Chosen by Leading Pharmaceutical
Company
Zumatrix, Inc. announced that Matrix Sample Tracking software has been chosen
by the Research Division of a major, multi-national pharmaceutical company.
It is being implemented at sites in America, Europe and Asia to track samples
and slides through the entire pre-clinical, Safety Assessment Division.
Peter Mansfield, President of Zumatrix said that the initial contract is for
100 concurrent users at three sites world-wide, with a single Oracle database
within the US. He said that the configurability and flexibility of Matrix
software was a major factor in winning the contract and that the project from
start to validation and completion would be completed in six months. At present
it is right on schedule. Matrix software is developed by Autoscribe,
Ltd in an ISO 9001-2000 certified process at Riseley, near Reading, Berkshire
(UK). The latest releases of Matrix use the latest Microsoft .NET platform
in order to deploy easily and quickly. Zumatrix, Inc provides software
products and support for laboratories throughout North America and is the
exclusive distributor for Autoscribe, Ltd. For details, visit http://www.zumatrix.com
or http://www.autoscribe.co.uk.
Sapio Sciences Releases Copy Number Variation
(CNV) Analysis Tool For Illumina Infinium Arrays
Sapio Sciences has announced Exemplar Analytics 4.0.8, the first commercial
solution, outside of Illumina, to provide CNV analysis for the Illumina family
of arrays. Copy number variation analysis is a powerful and widely used method
for identifying insertions and deletions in the genome. The identification
of these chromosomal alterations is critical in understanding cancer as well
as other serious diseases. This release of Exemplar Analytics also includes
the following new features: Full support of all Illumina DNA Analysis BeadChips
from the Human-1 to Human1M BeadChip; Principal Component Analysis for admixture
corrections; Proper Allele counting of Hemizygous SNP’s; Complete update
of the annotations database with current information from dBSNP, Entrez Gene
and Gene Ontology; and, Multi-Processor support for permutation corrections
on statistics.
Full Support of Copy Number analysis for the Affymetrix 10K-500K, 5.0 and
6.0 arrays. "We have seen significant demand for an Illumina copy number
variation analysis program from both our customers and prospects. With this
release we now offer a comprehensive copy number variation solution for the
researchers using either Illumina or Affymetrix arrays. We believe this valuable
tool will further researchers understanding of the most serious diseases afflicting
humans.” According to Kevin Cramer, CEO at Sapio, “When you combine
this with our built in annotations database, 80 additional statistics in support
of Genome-Wide Association Studies, Quantitative Trait Analysis and Family
based studies, Exemplar Analytics is a one stop solution for researchers undertaking
genetics based studies.” For details, visit http://www.sapiosciences.com.
Bruker Companies Announce the Opening of
a Modern Chinese Applications,
Demonstration and Customer Training Center in Beijing
During the BCEIA 2007 conference, Bruker BioSciences Corp. and the Bruker
BioSpin group of companies have announced the official opening of their new
Beijing modern applications, demonstration and customer training laboratory,
showcasing a wide selection of novel life science and materials research,
as well as industrial analysis systems. The new demonstration and training
facility includes sample preparation areas and laboratory space equipped with
the very latest systems from each of the Bruker companies. Clive Seymour,
Bruker Daltonics Vice President for Asia-Pacific, commented: "Our new
and expanded demonstration facility provides the opportunity for scientists
to investigate a wide range of applications on our innovative systems, together
with obtaining training, demonstrations and advice from Bruker's highly qualified
and experienced Beijing team of application scientists. We will provide workshops
and training courses here to ensure that our customers gain the maximum benefit
from their Bruker products and solutions." The new Bruker combined Beijing
Demonstration Centre is located at 11 Zhong Guan Cun, South Avenue, Beijing.
For details, visit http://www.bruker.com.cn.
QATrax Releases Management Reports Solution
for Test Labs
QATrax has released Management Reports v1.1, which ships October 2007. This
product has been in use for several years. The new version is based on Microsoft's
.NET. The reports are faster and simpler to use.
Significant enhancements to the Management Reports module provide Users with
a flexible tool to access information. Users can selectively grab information
and export to Excel and other formats. QATrax is evolving to easily handle
Dynamic Scheduling in Active Environments. Auto-Scheduling provides a significant
edge in the dynamic and complex product development world. QATrax will help
minimize the disruptions and time spent in accommodating schedule changes
and the downstream “ripples” they cause. With test labs spread
around the globe, your goal is to manage the entire process. Our goal is to
simplify the task. To provide visibility and process, TraxStar envisions a
Global Test Lab Network linking labs inside the firewall while providing access
to and by other constituencies; industry groups, independent test labs and
customers. For details, visit http://www.traxstar.com.
PerkinElmer Introduces Series 200EP Photo Diode
Array Detector
PerkinElmer has introduced a new Photo Diode Array (PDA) detector to expand
the capabilities of their Series 200 HPLC offering – the Series 200EP
(Enhanced Performance) PDA. The new detector provides deeper insights
into results through superior linearity and best-in-class spectral integrity,
allowing uncompromised quali-quantitative analysis of complex mixtures. With
its wide linear dynamic range and low drift, the Series 200EP PDA detector
is the ideal tool for demanding quantitative analyses like impurities in drug
or environmental samples with wide variation in compound concentration. Coupled
with TotalChrom Chromatography Data Systems, the Series 200EP PDA detector
is fully network compatible. In addition, IRIS® Spectral Processing
Software provides intuitive spectral data processing, all protected under
a fully 21 CFR Part 11-compliant architecture. For details, visit http://www.perkinelmer.com/Series200EPPDA.
RTS Life Science Extends its Bench Top Instrument
Range
Since its launch over the summer, RTS Life Science’s Benchtop Assistant
Range of instruments has now been expanded to address a wider range of automation
requirements for pressurised metered dose and dry powder
inhalation devices. The whole range now spans the entire gamut of automation
levels for the testing of pMDIs and DPIs. Mark Fish, business manager for
Drug Delivery Automation at RTS Life Science, commented: “Offering an
entry level solution for all laboratories, RTS’s Benchtop Assistant
Range enables analysts currently using manual methods to benefit from the
reductions in data variance and improvements in throughput offered by automation.
Our new instruments eliminate manual intervention in some of the more
physically demanding aspects of the testing, such as controlled shaking of
the devices. This reduces the risk of analyst exposure to repetitive
strain injuries (RSI) and work related upper limb disorders (WRULD).”
Joining the Benchtop Assistant systems and aimed at the those who need a higher
level of automation, but are not yet ready for full automation, the new Walkaway
Specialist Range automates many of the steps associated with analytical test
methods. This includes waste firing; test firing and dose wash down.
Semi-automated Walkaway Specialist units are suitable for method validation
and standalone use in analytical development and quality control environments,
and as a precursor to the deployment of RTS’ fully automated and well
respected, Process Master Range. For details, visit http://www.rtslifescience.com/default.asp?id=1353&news=528.
Labtronics Announces Fully Integrated LIMS
Interfacing for Chromeleon CDS
Labtronics Inc. has announced that the upcoming release of LimsLink CDS will
introduce a seamless, embedded LIMS interface for Chromeleon CDS that lets
analysts interact directly with their LIMS, without having to leave their
CDS client. The LimsLink CDS embedded interface is easy for analysts to work
with, as there is no additional software for them to learn. Training requirements
are minimal so analysts quickly realize the benefits of eliminating manual
interaction with LIMS. Analysts working in their Chromeleon client simply
click on the new 'Create Sequence' button on the Chromeleon toolbar to automatically
create complete Chromeleon sequences from LIMS worklists. This direct interface
speeds up setup time and eliminates the possibility of samples being missed
due to setup errors. Sample results are sent to LIMS using regular Chromeleon
reporting procedures. There are no new procedures to learn, no time spent
on manual data transfer and no data entry errors - results go directly
into the LIMS, as soon as the report is ready. The new LimsLinkCDS embedded
interface for Chromeleon is part of the upcoming LimsLink CDS release that
also includes Labtronics popular embedded interfaces for Empower, ChemStation
Plus and TotalChrom. For details, visit http://www.labtronics.com/llcds.htm.
Bruker BioSciences Reports Financial Results
for the Third Quarter of 2007
Bruker BioSciences Corporation has reported its financial results for the
three and nine months ended September 30, 2007. For the third quarter of 2007,
revenue increased by 25% to $131.6 million, compared to revenue of $104.9
million in the third quarter of 2006. Excluding the effects of foreign currency
translation, third quarter 2007 revenue increased by 20% year-over-year. Net
income in the third quarter of 2007 was $8.7 million, or $0.08 per diluted
share, compared to net income of $3.0 million, or $0.03 per diluted share,
in the third quarter of 2006. Included in third quarter of 2007 net income
was a one-time tax benefit of $2.4 million, or $0.02 per diluted share, related
to the revaluation of the Company's deferred tax assets and liabilities as
a result of a tax law change in Germany enacted in the third quarter of 2007
which will decrease the statutory German corporate income tax rate beginning
in 2008. During the nine months ended September 30, 2007, revenue increased
by 21% to $363.8 million, compared to revenue of $300.2 million during the
nine months ended September 30, 2006. Excluding the effects of foreign currency
translation, revenue for the nine months ended September 30, 2007 increased
by 16% year-over-year. Net income during the nine months ended September 30,
2007 was $17.5 million, or $0.16 per diluted share, compared to net income
of $8.8 million, or $0.09 per diluted share, during the nine months ended
September 30, 2006. Commenting on the third quarter, Frank Laukien, President
and CEO, said: "We are pleased with our top-line performance in the third
quarter, with all three operating divisions delivering double digit growth
year-over-year. Moreover, we continue to improve gross profit margins and
leverage our operating expenses, resulting in year-over-year improvements
to our operating income margin." For details, visit http://www.bruker-biosciences.com.
Thermo Fisher Scientific
Selected by China Doping Control Center to Supply Sports Doping Testing Instrumentation
at the 2008 Beijing Olympics
Thermo Fisher Scientific Inc., the world leader in serving science, has announced
that the China Doping Control
Center (CDCC) has selected Thermo Scientific instruments and software for
its sports testing program at the 29th Olympic Games in Beijing. The CDCC
has been accredited by the Chinese government and the International Olympic
Committee (IOC) to conduct all doping control analyses during the 2008 Olympic
Games. Identifying illegal performance-enhancing substances that are used
in sports competition is a growing global challenge, one made more difficult
by the development of ever more sophisticated drugs that are increasingly
difficult to detect. The analytical systems Thermo Fisher supplied to CDCC
are ideally suited for this challenge, providing the high specificity, low
limits of detection, high throughput and reliability required in today's sports
testing environment. Thermo Fisher provided the CDCC with a range of high
precision and performance Thermo Scientific instrumentation, including two
DFS Sector Field GC/MS systems, a DELTA V isotope ratio mass spectrometer
and four triple-quadrupole TSQ Quantum Access LC/MS systems. These instruments
and associated software will enable the CDCC to cope with the high volume
of samples expected at the 2008 Olympic Games. Thermo Fisher has also agreed
to provide 24/7 technical and application assistance to the CDCC to ensure
uninterrupted operation and successful, secure handing of athlete samples
throughout the games. The CDCC sports doping testing program will start even
before the opening of the competition, and continue from athletes' check-in
at the Olympic Village until the end of the Games. All samples will be analyzed
strictly in accordance with the IOC anti-doping rules for banned substances.
With many thousands of samples to run and a long list of banned substances
to potentially identify, the CDCC placed a high priority on acquiring automated
systems that provide high accuracy, sensitivity and throughput. For details,
visit http://www.thermo.com.
GenoLogics Welcomes New VP Finance and VP
Products to Senior Management Team and Appoints New Chair of the Board
GenoLogics, a leading developer of lab and data management
software solutions for life sciences research, has added Sal Sanci, Vice President
of Products, and Paul Ford, Vice President of Finance, to the management team.
Sal Sanci is a technology community veteran with over 20 years of experience.
He most recently held the position of VP Technology at Teligence. Sal
brings years of product & technology development, management and operational
experience to GenoLogics. He will be a critical member of the team in
2008 as the Company aims to launch two new products, and he will also ensure
the successful adoption of its newest product Geneus. Sal oversees the
software development, QA and product management teams. Unifying these
teams will ensure smooth communications and seamless product delivery to the
market. Sal brings VP-level experience from Teligence, Pivotal Corporation,
DocsFulcrum and Meridian Technologies to GenoLogics. Paul Ford joins
GenoLogics from private equity firm PineRidge Partners in Tokyo, where he
most recently held the position of Executive Director. Paul is a University
of Victoria, Commerce graduate and holds a CA designation. At PineRidge,
Paul was responsible for structuring, financing, and negotiating acquisitions
in the resorts, digital media and industrial sectors, as well as managing
portfolio companies. Prior to PineRidge Partners, he was employed by
KPMG for 12 years and was responsible for M&A advisory services, audit
and assurance projects. Paul brings strong business acumen to GenoLogics
and experience in financial matters from many regions including London, San
Francisco, Hong Kong and Tokyo. In addition to the two new executives on the
GenoLogics team, the Company is proud to announce the appointment of Don Listwin,
as Chairman of the Board of Directors. Don is also a technology industry
veteran, formerly the number two executive at Cisco Systems, and has been
a member of GenoLogics’ Board since early 2006. In addition to
recently being appointed Chairman of the GenoLogics Board, Don is also the
Chair of the Board of Canary Foundation and Sana Security. In 2004,
Don Listwin founded Canary Foundation, the only non-profit organization in
the United States entirely dedicated to the early detection of cancer. Today
the Canary Foundation is investing in research to catalyze the development
of a biomarker discovery platform for early detection of cancer. Don’s
experience overseeing technology companies at the board level and his previous
experience on the GenoLogics Board will serve him well as he takes on the
lead position. For details, visit http://www.genologics.com.
Savi Technology Taps Solar Energy to Power
RFID-Based Asset Tracking Systems
Savi Technology has recently begun deploying solar-powered
Radio Frequency Identification (RFID) readers and signposts, enabling customers
in the defense and commercial sectors to conserve energy and reduce costs
while tracking supplies in real-time. Solar energy provides an energy
efficient and environmentally friendly power source for users’ RFID
hardware, and also eliminates the need to install electrical infrastructure
in remote areas where there is no fixed reader infrastructure. Savi engineers
mounted solar panels and RFID signposts on poles located at a major U.S. Army
supply facility in Kuwait. The solar-powered signposts activate RFID tags
attached to vehicles or pieces of equipment. The tags then report the
assets’ positions to nearby RFID readers, which relay the information
to Savi Site Manager software that automatically updates the assets’
latest location. These tools enable the facility to track more than
25,000 tags per day. "We continue to have challenges with providing adequate
power for the installation of RFID sites in austere locations,” said
Lt. Col. Patrick Burden, U.S. Army Product Management Office of Joint Automatic
Identification Technology (PM J-AIT). “We are always looking for
innovative ways to address these critical issues to support Warfighter needs.”
PM J-AIT serves as a single point of contact for acquisition support and technical
expertise for Joint Services, Federal agencies, NATO, and multi-national forces.
Plans are underway with the U.S. Department of Defense to expand the use of
solar-powered applications to other areas in the Middle East and beyond. On
the commercial side, Savi Networks operates an RFID-based network in Colombia
that also leverages solar energy to power Savi RFID signposts and readers
that track the status and security of containerized cargo shipments managed
by Emprevi Ltda., a Colombia-based provider of logistics and security services
for major importers and exporters. Savi Networks, a joint venture in which
Savi Technology holds a majority interest, installed solar-powered panels
at strategic supply chain checkpoints, including source factories and port
facilities, to monitor in-transit goods manufactured in and exported from
Colombia. "Solar energy powers some of the more remote sections of Emprevi’s
RFID network that would otherwise lack a constant, dependable power source,”
said Mauricio Barberan Canas, President of Emprevi. “While taking
advantage of a clean, renewable energy source, the system also leverages highly
advanced information and security technologies that greatly improve Emprevi’s
supply chain security, visibility, and management.” For details, visit
http://www.savi.com.
Labtronics Reintroduces Collect Licensing
Plan
Labtronics has announced the re-introduction of their 'per installation' license
for Collect - a leading software solution for RS232 instrument data collection.
Under the new licensing plan a single copy of Collect licensed for installation
on a single PC, can concurrently collect data from multiple RS232 instruments
(maximum 99), for only $495. "Collect has always provided an extremely
fast return on investment by eliminating manual data entry and transcription
errors, says Mike DeWitte, Vice President of Labtronics’ Device Integration
Group. The 'per installation' license structure delivers maximum value to
Collect users by allowing them to connect multiple instruments to a single
copy of Collect, on a single PC." Along with the revision to the Collect
licensing, Labtronics also announced that the U.S. / Canadian list prices
for Collect will be harmonized at $495, reflecting the current status of the
Canadian dollar. For details, visit http://www.labtronics.com/col.htm.